Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark
OPEN PloS one | 3 Dec 2016
S Jordan, JK Morris, GI Davies, D Tucker, DS Thayer, JM Luteijn, M Morgan, E Garne, AV Hansen, K Klungsøyr, A Engeland, B Boyle and H Dolk
Hypothesised associations between in utero exposure to selective serotonin reuptake inhibitors (SSRIs) and congenital anomalies, particularly congenital heart defects (CHD), remain controversial. We investigated the putative teratogenicity of SSRI prescription in the 91 days either side of first day of last menstrual period (LMP).
* Data courtesy of Altmetric.com